Podcasts about pharmd

This week's TWIRx puts the pedal to the metal—literally. Host Todd Eury dives into the surprising parallels between racing 150+ MPH and building a pharmacy business from the ground up. Special guest Charles Hoopes, co-owner of S&H Motorsports, joins the show alongside Stephen Beckman, CEO of YARAL Pharma, to preview the upcoming “Geezer Race” on Saturday, July 19th, sponsored by YARAL. Charles shares the intense highs and lows of becoming a drag racing team owner—from financial risk to the emotional rollercoaster of chasing a dream. His story mirrors the grit and resilience required to own and operate an independent pharmacy today.

Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginOut of all the hats that pharmacy owners need to wear, advocacy is arguably one of the most important. Yet too many pharmacy owners underestimate their ability to influence meaningful change.So how can pharmacy leaders advocate effectively and ensure their voices are heard in critical policy discussions?In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with Dr. Cole Sandlin, PharmD and Owner of Fred's Pharmacies to break down: The key takeaways from the pharmacy fly-inHow bipartisan support is driving momentum for pharmacy initiativeThe role of AI in strengthening pharmacy operationsAnd more!More About Our Guest:Cole Sandlin, PharmD is a 2008 graduate of Samford University McWhorter School of Pharmacy and the owner of Fred's Pharmacy in Hamilton, Alabama.Growing up in Hamilton, his grandfather, Fred C. Sandlin, founded Fred's Pharmacy in 1951. Cole's father, Fred Jr., took over from his dad and in 2014 Cole and wife Jill bought the pharmacy from his dad.   Learn more about Cole and Fred's Pharmacies:Cole Sandlin LinkedInFred's Pharmacies WebsiteFred's Pharmacies InstagramStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP Twitter More Resources on these Topics:Podcast – The One Big, Beautiful BillPodcast – Driving Independent Pharmacy Profitability in 2025Podcast - AI, Audits, & Advocacy: The Pharmacy Survival GuidePodcast - Pharmacy Advocacy: Going Beyond Patient Care for Your Community

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joined Over the Counter to discuss the importance of insulin delivery and how advancements in this space are expected to improve diabetes outcomes.

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, recap some of the biggest clinical trials presented at the American Diabetes Association (ADA) 2025 conference in Chicago, Illinois. 00:00 Introduction 2:04 The Vertex Trial 6:57 The T1D Trial 15:23 The Achieve 1 Trial

In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, continue their recap of ADA's 2025 Scientific Sessions, spotlighting 3 more of the top clinical trials focused on obesity and type 2 diabetes. 00:00:00 Intro 00:00:31 BELIEVE Trial 00:08:11 Phase 2 Maritide Trial 00:17:12 CATALYST-2

On this episode, we evaluate current guidelines and evidence-based treatment strategies for managing insomnia, including both pharmacological and non-pharmacological approaches. We compare and contrast the efficacy, safety profiles, and appropriate use of pharmacologic agents, behavioral therapies, and lifestyle interventions for treating insomnia.  Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

Artificial intelligence (AI) will bring many opportunities to the pharmacy profession, but it can be tempting to use AI in place of critical thinking or reliable research around drug information questions (DIQs). One must wonder, will the pharmacist be held liable if AI gets it wrong? Guest Authors: Elizabeth B. Hearn, PharmD, BCACP, CDCES; Karlyn E. Hood, PharmD, BCPS; Abigail L. Torres, PharmD Music by Good Talk

The latest episode of the Astonishing Healthcare podcast dives into the functionalities and real-world impact of Rx Smart Save, a low-cost alternative program designed to reduce medication costs for both patients and plan sponsors. Jackie Lolos, PharmD, and Haleh (Halls) Campbell, PharmD, join Justin Venneri in the studio for a discussion highlighting the innovation and care behind this clinical program.Jackie and Halls outline how the two levels of Rx Smart Save work, with Level 1 empowering members to independently switch to lower-cost, clinically equivalent medications via notifications on the Capital Rx app or web portal. Level 2 increases access with a proactive, high-touch approach, where a team of pharmacists and specialists assist members, prescribers, and pharmacies throughout the process. Halls also shares a quick case study demonstrating how one retiree saved $75 per prescription by switching from an injection-based migraine treatment to a tablet, and Jackie explains how modern technology aids the process..Related ContentAH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmDPharmacy Benefits 101: Building an Award-Winning Call Center from ScratchAH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmDSigns it is time to change your PBM vendor, and how to overcome common hesitations (Capital Rx / Benefits Pro)For more information about Capital Rx and this episode, please visit Capital Rx Insights.

Wondering whether to contribute to a Roth or Traditional retirement account? Tim Ulbrich and Tim Baker break down key factors like tax brackets, Roth 401(k) access, and long-term planning tips to help you decide. Episode Summary One of the most common questions we get is: Should I contribute to a Roth or Traditional retirement account? In this episode, YFP Co-Founder & CEO, Tim Ulbrich, PharmD, and YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP®, break down the key factors to consider when deciding between Roth and Traditional contributions, including: ✅ Your current and projected future tax bracket ✅ How much you've already saved in each account type ✅ Roth 401(k) availability through your employer ✅ State income tax implications ✅ Whether you have the cash flexibility to consider Roth conversions ✅ How the Roth IRA's freedom from required minimum distributions (RMDs) can be a valuable planning tool If you've ever found yourself wondering which retirement bucket to prioritize, or if you're simply trying to be more tax-savvy with your savings, this episode is for you.

Brett Barker, PharmD, joined Over the Counter to discuss Iowa's recent signing of PBM reform and what it might mean for pharmacies and other states looking to enact similar legislation.

Matt Bertsch is the Director of Education in Pharmacy for Sun Life Health. He oversees the organization's education strategy, including the four pillars, which are: Education of Future Health Care Workers Education of Ourselves Education of Our Communities Education of Our Patients Host Kristen Snair dives into a series of topics with Matt, including: The role of a 340B Pharmacy, the value of a Federally Qualified Health Center (FQHC), and what inspires him personally and professionally as a leader in this industry?

On the latest episode of The Huddle, we're joined by Jay Shubrook, DO, BC-ADM, FACOFP, FAAFP, Anne Lee, MEd, RDN, CDCES, and Clipper Young, PharmD, MPH, as they talk about Touro University' unique Mobile Diabetes Education Center (MOBEC). They explain how the center was formed, the services MOBEC provides, and how others can replicate this work to serve and educate a greater population of people with and at risk for diabetes.Learn more about MOBEC here: Touro University Californiahttps://diabetesjournals.org/clinical/article/42/1/125/153645/Community-Based-Diabetes-Awareness-Strategy-With  Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Master the latest approaches for treating venous thromboembolism with expert tips on direct oral anticoagulant (DOAC) selection, dosing, and duration. Learn how to tailor anticoagulation for special populations, handle treatment failures, and navigate long-distance travel risks. We're joined by Dr. Tara Lech, PharmD, CACP (Beth Israel Lahey Health, @AnticoagPharmD, @anticoagpharmd.bsky.social‬). Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Case 1 from Kashlak Choosing the right anticoagulant Distal deep vein thrombosis management Anticoagulation in special populations Case 2 from Kashlak Understanding treatment failure Anticoagulation reversal agents Outro Credits Producer, Writer, Show Notes, Infographic, Cover Art: Ben Furman  Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Leah Witt, MD Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Tara Lech, PharmD  Disclosures Dr. Lech reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: Grammarly  Let Grammarly take the busywork off your plate so you can focus on high-impact work. Download Grammarly for free at Grammarly.com/PODCAST. Sponsor: Freed CURB50 to get $50 off your first month when you subscribe at freed.ai Sponsor: JournalFeed Try JournalFeed free for 7 days—and get 20% off your first year with code CURB25 at journalfeed.org/curb. 

According to a recently published study by Bayer Consumer Health, being poor makes it more likely that you will suffer from self-treatable health conditions. But it also means you will find it harder to take advantage of self-care solutions. In this episode of the Over the Counter podcast, HBW Insight speaks to Bayer Consumer Health's global medical access lead Emese Csoke about the issues that the study raises for the self-care industry, not least how widening access to self-care solutions can be balanced with equity with regards to affordability. For Csoke, ways forward include partnerships between public and private sector stakeholders and investments in digital self-care. Timestamps 2:00 – Introductions 2:50 – Bayer Consumer Health's RISE initiative 4:00 – Self-care is hardest for those who need it most 5:45 – Implications for the consumer health industry 8:20 – Self-care's “double burden” 10:15 – Profit vs people? 16:30 – Public-private partnerships 19:00 – Digital self-care 22:40 – Impact of RISE so far Guest Bio Emese Csoke is currently serving as global strategy director for regulatory, medical, safety, quality, and compliance at Bayer Consumer Health. In this role, she plays a pivotal part in advancing health equity by designing and implementing strategic initiatives that expand access to self-care. Emese led the creation of the strategic pillar RISE – the Research Initiative for Self-care Equity – and authored a peer-reviewed publication on the impact of socioeconomic determinants on health outcomes for self-care conditions. As a lead on Bayer's “dynamic shared ownership” model, Csoke is also driving force behind organizational transformation and innovation. Csoke holds a PharmD and a degree in Clinical Development Science from Semmelweis University and is certified as a medical science translator.

Thinking about changing jobs or just got promoted? In this episode, Tim and Tim cover 7 key financial considerations, from negotiating offers to managing benefits, to help you navigate the transition with clarity and confidence. Episode Summary If you recently changed jobs or just landed a promotion, congratulations! A new opportunity, whether internal or external, often brings exciting possibilities…and important financial decisions. In this episode, 7 Key Financial Considerations During a Job Transition, YFP Co-Founder & CEO, Tim Ulbrich, PharmD is joined by YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP® to walk you through the most important financial areas to think about when navigating a job change or stepping into a new role. They cover how to: ✅ Evaluate and negotiate a new offer ✅ Understand your updated benefits package ✅ Make a plan for your old 401(k) ✅ Align your new compensation with your financial goals ...and more. Whether you're in the early stages of a transition or already in your new role, this episode is your financial checklist to move forward with clarity and confidence. Mentioned on the Show YFP 384: Beyond Salary: Negotiating Your Value in the Workplace Never Split the Difference by Chris Voss YFP 328: How to Navigate Open Enrollment & Employer Benefits YFP Episode 408: What Should You Do With an Old 401(k) YFP Episode 404: 5 Key Questions to Ask When Hiring a Financial Planner  

Are the viral claims about dangerous ingredients in ivermectin true? Let's set the record straight. Pharmacist Bryana Gregory from Physician's Preference Pharmacy addresses recent concerns circulating online about Ivermectin formulations, including fear-based misinformation around additives like Polysorbate 80 and Titanium Dioxide. Bryana breaks down the differences between animal-grade Ivermectin products and the carefully compounded human oral capsules provided by the pharmacy. She explains how compounding pharmacists source pure ingredients, verify potency, and ensure products are free from allergens and unwanted excipients. You'll also learn why taking veterinary Ivermectin (like horse paste or injectable liquids) is not only unnecessary but potentially harmful, and how to safely and confidently use pharmaceutical-grade Ivermectin with your doctor's guidance. If you've seen the rumors online, this episode is a must! For more information about Physician's Preference Pharmacy, please call us at 281-828-9088, or visit https://physicianspreferencerx.com/. Watch now and subscribe to our podcasts at www.HotzePodcast.com. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!

Listen in as our expert panel discusses practical considerations for starting and optimizing antidepressants for treating depression and anxiety.  You'll listen to panelists cover various aspects of antidepressant use, such as serotonin syndrome, QT prolongation, and weight gain concerns.Special guest(s):Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP Director of Pharmacy and Residency Programs, New York State Office of Mental Health State University of New York at Buffalo School of Pharmacy and Pharmaceutical Sciences Sarah E. Grady, PharmD, BCPS, BCPPProfessor, Drake University College of Pharmacy and Health SciencesClinical Pharmacist, Inpatient Behavioral Health Unit, Broadlawns Medical CenterYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in May 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights.Clinical Resources: Choosing AntidepressantsSwitching AntidepressantsCombining and Augmenting AntidepressantsPharmacotherapy of Anxiety Disorders in AdultsSend us a textIf you're not yet a subscriber, find out more about our product offerings at trchealthcare.com. Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Dr. Meg Mill is a PharmD and Functional Medicine expert, specializing in neuro-digestion and its profound impact on overall health. Her renowned 3 R Protocol - Regulate, Repair, and Rewire - offers a holistic approach to improving both physical and mental well-being. A bestselling author and frequent media contributor, Dr. Meg has been featured on major networks and in leading publications, sharing her expertise with audiences worldwide. CONNECT WITH HER https://megmill.com Subscribe to this channel now!  https://www.youtube.com/user/lunidelouis/?sub_confirmation=1    ---------------------------------------------------- Join our exclusive Facebook group @ https://www.facebook.com/groups/339709559955223  --------------------------------------------------- Looking for accountability to do your morning routine -- join us tomorrow morning, it's FREE:   https://bestmorningroutineever.com/  ----------------------------------------­­­­­­­-------------

Dyslipidemia remains a major contributor to cardiovascular disease, and pharmacists play a key role in optimizing therapy and improving outcomes. This episode reviews recent updates in guidelines, pharmacologic options, and practical counseling tips for supporting patients with lipid disorders. Tune in to strengthen your clinical impact and support long-term health for the patients you serve. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJanelle Ruisinger, PharmD, FAPhAClinical ProfessorThe University of Kansas School of PharmacyPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current guidelines and evidence-based pharmacologic options for managing dyslipidemia.2. Identify key counseling strategies pharmacists can use to support adherence and improve lipid-related outcomes.0.05 CEU/0.5 HrUAN: 0107-0000-25-226-H01-PInitial release date: 6/30/2025Expiration date: 6/30/2026Additional CPE details can be found here.

Dyslipidemia remains a major contributor to cardiovascular disease, and pharmacists play a key role in optimizing therapy and improving outcomes. This episode reviews recent updates in guidelines, pharmacologic options, and practical counseling tips for supporting patients with lipid disorders. Tune in to strengthen your clinical impact and support long-term health for the patients you serve. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTJanelle Ruisinger, PharmD, FAPhAClinical ProfessorThe University of Kansas School of PharmacyPharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current guidelines and evidence-based pharmacologic options for managing dyslipidemia.2. Identify key counseling strategies pharmacists can use to support adherence and improve lipid-related outcomes. 0.05 CEU/0.5 HrUAN: 0107-0000-25-226-H01-PInitial release date: 6/30/2025Expiration date: 6/30/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Medtronic, and Vertex.

The Pharmacist Authors Series is back! The goals of the series are to (1) introduce you to new books/authors and (2) inspire you to write a book and narrate it too.    The FULL show notes with links to previous episodes of The Pharmacist Authors Series on https://thepharmacistsvoice.com/podcast.    2025 Pharmacist Authors Series June — Jerry Levin, PhD, LMT talks about Affirm Yourself: 15 Principles to Retrain the Voice in Your Head. July — Ashley Walker, PharmD talks about her chapter in Expanding Your Brilliance: Creating Effortless Abundance while Navigating Business and Motherhood. August — 4 guests: Rosa Hart, RN (author), Simi Burn, PharmD (ghost writer), Janan Sarwar, PharmD (publisher), and Julie Walthers (audio engineer). We will discuss Rosa's book, how she wrote and published it, and how she collaborated with an audio engineer to record the audiobook.    Affirm Yourself by Dr. Jerry Levin focuses on the power of affirmations to counter negative self-talk. During our conversation, you'll learn what affirmations are, why we need them, how the book helps you write them, how the book is helping me and my son, advice for aspiring authors, and more.    Links from this episode Amazon link for Affirm Yourself: 15 Principles to Retrain the Voice in Your Head. E-book and print available Summer 2025. Audiobook available later in 2025. Check out my review ⭐️⭐️⭐️⭐️⭐️ when you shop for Jerry's book. Leave a review for after you read it. Visit Jerry's website: https://jerrylevinauthor.com/  Read the Google Doc with sample affirmations for aspiring authors. https://docs.google.com/document/d/1mV3yKz8-ZloHNeBDoEdDINnKIaW1FzTI-QybKat0-Js/edit?usp=sharing  Zoom Q&A session link on July 14th, 7 PM Eastern Time. (No requirement to read the book in advance of the session.) https://us02web.zoom.us/j/84400790985?pwd=Aa4QX9s4LoInujKagwQDAY9mvqWYVu.1    Pharmacist Authors Series 2024 Part 1 of 3 (June) Episode 282 with Steve Leuck, PharmD - A Pharmacist's Story An Authentic Tale of True Love, Family, Addiction, and the Practice of Pharmacy Part 2 of 3 (July) Episode 288 Helen Sairany, PharmD - The We You Don't See:  Understanding the Long Shadows of Trauma Part 3 of 3 (August) Episode 293 Kim Newlove with Publishing in Doses Co-Founders Janan Sarwar, PharmD and Theary Chhim, PharmD plus audio engineer, Julie Walthers.    Pharmacist Authors Series 2023 (Part 1 of 15) June 5, Introduction to the Pharmacist Authors Series (Episode 220) (Part 2 of 15) June 9, The Pharmacist's Voice ® Podcast Episode 221:  Interview with Salam Kabbani, PharmD about her book: COVID Long-Hauler:  My Life Since COVID (Part 3 of 15) June 12, The Pharmacist's Voice ® Podcast Episode 222:  Interview with audio engineer Julie Walthers from Whole Story Studio: https://www.wholestorystudio.com/  (Part 4 of 15) June 16, The Pharmacist's Voice ® Podcast Episode 223 Interview with Erin L. Albert, PharmD on her book The Life Science Lawyer Part 5 of 15) June 19, The Pharmacist's Voice ® Podcast Episode 224 Interview with Sue Ojageer, PharmD on her children's book The Pharma Heroes:  The Power of Precision Medicine (Part 6 of 15) June 23, The Pharmacist's Voice ® Podcast Episode 225: Interview with Tony Guerra, PharmD about his Pharmacist Residency and Career Series (8 books) (Part 7 of 15) June 26, The Pharmacist's Voice ® Podcast Episode 226:  Interview with Christina Fontana, PharmD about her book Moving Beyond the Counter:  Elevating into Heart-Centered Health Care through Entrepreneurship (Part 8 of 15) June 30, The Pharmacist's Voice ® Podcast Episode 227: Interview with Jade L. Ranger, PharmD, about her book Mustard Seed Mentality: Unscripted Pearls of Wisdom from a Wife, Mother, and Entrepreneur (Part 9 of 15) July 7, The Pharmacist's Voice ® Podcast Episode 229: Interview with RDML Pam Schweitzer, PharmD and her daughter Amy Graves about their children's book Alice and Jack Hike the Grand Canyon (Part 10 of 15) July 10, The Pharmacist's Voice ® Podcast Episode 230: Interview with Cory Jenks, PharmD about his book Permission to Care:  Building a Healthcare Culture That Thrives in Chaos (Part 11 of 15) July 14, The Pharmacist's Voice ® Podcast Episode 231: Interview with Donna Bartlett, PharmD about her book MedStrong:  Shed Your Meds for a Better, Healthier You - Aging Well Through Deprescribing  (Part 12 of 15) July 17, The Pharmacist's Voice ® Podcast Episode 232:  Interview with Frieda Wiley, PharmD about her book Telecommuting Psychosis:  From Surviving to Thriving While Working in Your Pajama Pants.  Plus, we touch on her 3 children's books in development. (Part 13 of 15) July 21, The Pharmacist's Voice ® Podcast Episode 233:  Interview with Tim Ulbrich, PharmD about his book Seven Figure Pharmacist:  How to Maximize Your Income, Eliminate Debt, and Create Wealth  (Part 14 of 15) July 24, The Pharmacist's Voice ® Podcast Episode 234:  Interview with LaQuoia Johnson, PharmD about her book How Rxacism Manifests Inside the Small World of Pharmacy (Part 15 of 15) July 28, The Pharmacist's Voice ® Podcast Episode 235:  Pharmacist Authors Series wrap-up (solo show)   Kim's websites and social media links: ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Buy my book on amazon.com https://amzn.to/4iAKNBs  ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting Course https://www.kimnewlove.com/podcasting   ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 336 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

In this episode, hear Allison Butts, PharmD, BCOP and Danielle Roman, PharmD, BCOP, share their insights on the best practices for incorporating antibody–drug conjugates (ADCs) into clinical practice including:An overview of ADC structure and mechanism of actionA topline review of data supporting the current FDA-approved indications for ADCs targeting HER2 and TROP-2 across multiple tumor typesAn in-depth look at common and serious adverse events with each approved ADC along with an overview of management strategiesEditor's note: On June 23, 2025, the FDA granted accelerated approval for a new indication for datopotamab deruxtecan, one of the antibody drug conjugates discussed in this podcast. Datopotamab deruxtecan is now also approved for adults with locally advanced or metastatic EGFR-mutated NSCLC who have received previous EGFR-targeted therapy and platinum-based chemotherapy. Program faculty:Allison Butts, PharmD, BCOPPharmacist Manager, OncologyClinical Pharmacist, Breast OncologyUK HealthCareMarkey Cancer CenterLexington, KentuckyDanielle Roman, PharmD, BCOPManager, Oncology Clinical Pharmacy ServicesAllegheny Health NetworkPittsburgh, PennsylvaniaProgram page:https://bit.ly/4lr7cT6

Does a 1% AUM fee really cost you 25% of your returns? Tim Ulbrich and Tim Baker run the numbers and give you a framework to evaluate the real cost and the real value of financial planning. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD, and YFP Co-Founder & COO, Tim Baker, CFP®, RLP®, RICP®, tackle a common concern about working with a financial advisor: Does paying a 1% fee for assets under management (AUM) really eat away a quarter of your investment gains over time? We run the actual numbers using compound interest calculators to see how much a 1% advisory fee could cost over the long term and whether the 25% claim holds true. But this episode isn't just about math. Tim and Tim also zoom out to look at the bigger picture: What's the ROI of the fee you're paying? Because it's not just about investment returns, it's also about the potential behavioral coaching, tax strategies, withdrawal planning, and comprehensive financial guidance that a good advisor brings to the table. Whether you're a die-hard DIY investor, already working with an advisor, or considering working with a financial planner for the first time, this episode will give you a practical framework to evaluate the real cost and real value of financial advice. Mentioned on the Show YFP YouTube Channel YFP 404: 5 Key Questions to Ask Before Hiring a Financial Planner  Vanguard: Putting a value on your value: Quantifying Vanguard Advisor's Alpha® The Investment Funds Institute of Canada. Financial Advice in Canada, November 2022. Kitces Quantifying the Value of Financial Planning Advice Record a Question to be Featured on an Ask YFP Episode Email YFP: info@yourfinancialpharmacist.com

Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, joined Over the Counter to discuss key takeaways in their organization's 2025 Trends in Drug Benefit Design Report.

Hypoglycemia can be subtle—or dangerously obvious—and knowing when and how to treat it is critical. In her first episode as our new Push Dose Pearls expert, Emergency Medicine Clinical Pharmacist, Haley Burhans, joins us to break it down. We discuss glucose thresholds by age, when to draw critical labs, and how to choose the right treatment—whether it's oral glucose, IV dextrose, or IM or intranasal glucagon. From neonates to older adults, Haley delivers practical, evidence-based pearls to help you manage low blood sugar safely and effectively in the ED. Was this episode helpful? What other medications would you like to learn more about? Hit us up on social media @empulsepodcast or at ucdavisem.com Hosts: Dr. Julia Magaña, Professor of Pediatric Emergency Medicine at UC Davis Dr. Sarah Medeiros, Professor of Emergency Medicine at UC Davis Guests: Haley Burhans, PharmD, Emergency Medicine Clinical Pharmacist at UC Davis Resources: Gandhi K. Approach to hypoglycemia in infants and children. Transl Pediatr. 2017 Oct;6(4):408-420. doi: 10.21037/tp.2017.10.05. PMID: 29184821; PMCID: PMC5682370. Rickels MR, Ruedy KJ, Foster NC, Piché CA, Dulude H, Sherr JL, Tamborlane WV, Bethin KE, DiMeglio LA, Wadwa RP, Ahmann AJ, Haller MJ, Nathan BM, Marcovina SM, Rampakakis E, Meng L, Beck RW; T1D Exchange Intranasal Glucagon Investigators. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study. Diabetes Care. 2016 Feb;39(2):264-70. doi: 10.2337/dc15-1498. Epub 2015 Dec 17. PMID: 26681725; PMCID: PMC4722945.. MD Calc GIR (Glucose Infusion Rate) Calculator **** Thank you to the UC Davis Department of Emergency Medicine for supporting this podcast and to Orlando Magaña at OM Productions for audio production services.

Dr. Katasha S. Butler, PharmD, MBA, joins The Freedom Forum to share her inspiring rise from a curious grade schooler in Illinois to a senior healthcare leader at Eskenazi Health. With over 20 years of experience, Dr. Butler reflects on her time at Spelman College and Butler University, her rapid ascent into pharmacy leadership, and the challenges she's faced as a Black woman navigating bias in highly regulated systems. She unpacks the complexities of formulary management, regulatory compliance, and strategic partnerships—all while leading with empathy and integrity. From people-first leadership to breaking down barriers in healthcare access and equity, Dr. Butler's story is a powerful testament to purpose, resilience, and the impact of showing up fully and authentically.

On this episode, we evaluate current guidelines and evidence-based strategies for managing chronic pain, including both pharmacologic and non-pharmacologic options. We compare and contrast the efficacy, safety profiles, and appropriate use of various analgesic classes and adjuvant therapies in chronic pain management. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com

We all know that clinician burnout negatively impacts the quality of patient care. That's why pharmacy residency accrediting bodies now emphasize resident well-being and professional sustainability as core components of residency training earlier in clinician careers. The American Society of Health-System Pharmacists (ASHP) Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies include a formal requirement for programs to address resilience, well-being, and burnout prevention, reflecting the increasing recognition of burnout in healthcare. Joining us to talk that out are Tony Huke, Senior Pharmacy Executive Director with Vizient Pharmacy Advisory Solutions and Kendra Gage, Inpatient Clinical Pharmacist and the PGY 1 Residency Program Director at UCHealth, University of Colorado Hospital in Aurora, Colorado.   Guest speakers:  Tony Huke, PharmD, BCPS, FASHP Senior Pharmacy Executive Director Vizient Pharmacy Advisory Solutions   Kendra Gage, PharmD, BCPS Inpatient Clinical Pharmacist PGY1 Pharmacy Residency Program Director UCHealth   Host:  Kerry Schwarz, PharmD, MPH  Senior Clinical Manager, Evidence-Based Medicine and Outcomes Center for Pharmacy Practice Excellence (CPPE)   Show Notes:  [01:11-03:25] What's new at the national level in terms of pharmacy resident resiliency and well-being [03:26-03:56] The intentionality of well-being in pharmacy residency programs [03:57-05:12] Examples from Kendra's program [05:13-06:40]  Program expectations to address resilience [06:41-08:33]  Assessment and potential metrics of resiliency programs [08:34-11:06]  The role of pharmacy leadership and residency program directors in resiliency [11:07-12:34] Impact of resiliency programs so far   Links | Resources: Accreditation Standards for PGY1 and PGY2 Pharmacy Residencies   Subscribe Today! Apple Podcasts Amazon Podcasts Spotify Android RSS Feed

Dr. Erin Thompson is a seasoned pharmacist and healthcare educator with nearly 20 years of experience in clinical care, teaching, and coaching. Living with multiple sclerosis, she combines professional expertise with personal experience to empower patients. She earned her BSPS and PharmD from the University of Toledo and completed a PGY-1 residency at UT Medical Center. She also holds a BSEd from BGSU. Through signature programs, tutorials, and speaking engagements, Dr. Thompson provides practical strategies for managing chronic illness, enhancing quality of life, and making informed health decisions. Recognized for her leadership, she received the Usher Smith Excellence in Innovation Award from the Ohio Pharmacists Association and completed the ACCP Professional Leadership Development Program. Dr. Thompson is a devoted mother of two and married to Eric, a fellow pharmacist

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of PharmacyPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.

Fatty liver disease affects a growing number of patients, often progressing silently until advanced stages. This episode highlights what pharmacists need to know about recent terminology changes, risk factors, pharmacotherapy updates, and key counseling strategies to support patients. Tune in to sharpen your clinical knowledge and help identify, manage, and educate patients at risk for this increasingly common condition.HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTSarah Wheeler, PharmD, BCACP, CDCESAssistant ProfessorVCU School of Pharmacy Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current terminology, risk factors, and stages associated with fatty liver disease.2. Identify evidence-based pharmacologic and non-pharmacologic strategies that pharmacists can use to support patients with or at risk for fatty liver disease.0.05 CEU/0.5 HrUAN: 0107-0000-25-219-H01-PInitial release date: 6/23/2025Expiration date: 6/23/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Is it Q-var or Q-vair? Find out today.   This is the 57th episode in my drug pronunciations series. In the episode, I divide QVAR and beclomethasone into syllables, tell you which syllables to emphasize, and share my sources. The written pronunciations are below and in the show notes on thepharmacistsvoice.com.    Note: we don't cover pharmacology in this series. Just pronunciations.   QVAR = KUE-var Q, like the letter in the alphabet (Q) Var, which rhymes with “far” Emphasize KUE (Q) Sources:  Patient Information in the prescribing information for QVAR on the FDA's website https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207921s000lbl.pdf for the written pronunciation. drugs.com for the spoken pronunciation.    Note: the pronunciation of Redihaler is red-ee-HAYE' ler. (It's a combo of “ready” and “inhaler.”)   beclomethasone = be-kloe-METH-a-sone Beh, like Becky Kloe, like a 4-leaf clover  Meth, like methane   A, which is a short “A” sound or a schwa “A” sound. It sounds like “Uh” Sone, similar to “zone” Emphasize METH Sources: MedlinePlus.gov (written) and Dr. Tony Guerra's YouTube channel (spoken)   If you'd like to recommend a drug name for this series, please reach out. Either send me a voicemail message or type a message under the contact tab on thepharmacistsvoice.com.    If you know someone who would like to learn how to say QVAR Redihaler or beclomethasone, please share this episode with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️   Apple Podcasts   https://apple.co/42yqXOG  Spotify  https://spoti.fi/3qAk3uY  Amazon/Audible  https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt   ⭐️ Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF   Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting).    Links from this episode  Patient Information Section for QVAR on the FDA's website https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020911s029s030lblPI.pdf (accessed 6-18-25) drugs.com - check out the “click and listen” feature MedlinePlus.gov (beclomethasone) https://medlineplus.gov/druginfo/meds/a681050.html  Tony Guerra, PharmD on YouTube beclomethasone video  The Pharmacist's Voice Podcast Episode 333, Pronunciation Series Episode 56 (pantoprazole)  The Pharmacist's Voice Podcast Episode 330, Pronunciation Series Episode 55 (oxcarbazepine) The Pharmacist's Voice Podcast Episode 328, Pronunciation Series Episode 54 (nalmefene) The Pharmacist's Voice Podcast Episode 326, Pronunciation Series Episode 53 (Myrbetriq) The Pharmacist's Voice Podcast Episode 324, Pronunciation Series Episode 52 (liraglutide)  The Pharmacist's Voice Podcast Episode 322, Pronunciation Series Episode 51 (ketamine) The Pharmacist's Voice Podcast Episode 320, Pronunciation Series Episode 50 (Jantoven) The Pharmacist's Voice Podcast Episode 318, Pronunciation Series Episode 49 (ipratropium) The Pharmacist's Voice Podcast Episode 316, Pronunciation Series Episode 48 (hyoscyamine) The Pharmacist's Voice Podcast Episode 313, Pronunciation Series Episode 47 (guaifenesin) The Pharmacist's Voice Podcast Episode 311, Pronunciation Series Episode 46 (fluticasone) The Pharmacist's Voice Podcast Episode 309, Pronunciation Series Episode 45 (empagliflozin) The Pharmacist's Voice Podcast Episode 307, Pronunciation Series Episode 44 (dapagliflozin) The Pharmacist's Voice Podcast Episode 304, Pronunciation Series Episode 43 (cetirizine)  The Pharmacist's Voice Podcast Episode 302, Pronunciation Series Episode 42 (buspirone)  The Pharmacist's Voice Podcast Episode 301, Pronunciation Series Episode 41 (azithromycin) The Pharmacist's Voice Podcast Episode 298, Pronunciation Series Episode 40 (umeclidinium) The Pharmacist's Voice Podcast Episode 296, Pronunciation Series Episode 39 (Januvia)  The Pharmacist's Voice Podcast Episode 294, Pronunciation Series Episode 38 (Yasmin) The Pharmacist's Voice Podcast Episode 292, Pronunciation Series Episode 37 (Xanax, alprazolam) The Pharmacist's Voice Podcast Episode 290, Pronunciation Series Episode 36 (quetiapine)  The Pharmacist's Voice Podcast Episode 287, pronunciation series ep 35 (bupropion) The Pharmacist's Voice Podcast Episode 285, pronunciation series ep 34 (fentanyl) The Pharmacist's Voice Podcast Ep 281, Pronunciation Series Ep 33 levothyroxine (Synthroid) The Pharmacist's Voice ® Podcast Ep 278, Pronunciation Series Ep 32 ondansetron (Zofran) The Pharmacist's Voice ® Podcast Episode 276, pronunciation series episode 31 (tocilizumab-aazg) The Pharmacist's Voice ® Podcast Episode 274, pronunciation series episode 30 (citalopram and escitalopram) The Pharmacist's Voice ® Podcast Episode 272, pronunciation series episode 29 (losartan) The Pharmacist's Voice Podcast Episode 269, pronunciation series episode 28 (tirzepatide) The Pharmacist's Voice Podcast Episode 267, pronunciation series episode 27 (atorvastatin)  The Pharmacist's Voice Podcast Episode 265, pronunciation series episode 26 (omeprazole) The Pharmacist's Voice Podcast Episode 263, pronunciation series episode 25 (PDE-5 inhibitors) The Pharmacist's Voice Podcast Episode 259, pronunciation series episode 24 (ketorolac) The Pharmacist's Voice ® Podcast episode 254, pronunciation series episode 23 (Paxlovid) The Pharmacist's Voice ® Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacist's Voice Podcast ® episode 245, pronunciation series episode 21 (naltrexone/Vivitrol) The Pharmacist's Voice ® Podcast episode 240, pronunciation series episode 20 (levalbuterol) The Pharmacist's Voice ® Podcast episode 236, pronunciation series episode 19 (phentermine)  The Pharmacist's Voice ® Podcast episode 228, pronunciation series episode 18 (ezetimibe) The Pharmacist's Voice ® Podcast episode 219, pronunciation series episode 17 (semaglutide) The Pharmacist's Voice ® Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacist's Voice ® Podcast episode 211, pronunciation series episode 15 (Humira®) The Pharmacist's Voice ® Podcast episode 202, pronunciation series episode 14 (SMZ-TMP) The Pharmacist's Voice ® Podcast episode 198, pronunciation series episode 13 (carisoprodol) The Pharmacist's Voice ® Podcast episode 194, pronunciation series episode 12 (tianeptine) The Pharmacist's Voice ® Podcast episode 188, pronunciation series episode 11 (insulin icodec)  The Pharmacist's Voice ® Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacist's Voice ® Podcast episode 180, pronunciation series episode 9 Apretude® (cabotegravir) The Pharmacist's Voice ® Podcast episode 177, pronunciation series episode 8 (metoprolol)  The Pharmacist's Voice ® Podcast episode 164, pronunciation series episode 7 (levetiracetam) The Pharmacist's Voice ® Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC)  The Pharmacist's Voice ® Podcast episode 155, pronunciation series episode 5 Trulicity® (dulaglutide)  The Pharmacist's Voice ® Podcast episode 148, pronunciation series episode 4 Besponsa® (inotuzumab ozogamicin) The Pharmacist's Voice ® Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacist's Voice ® Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacist's Voice ® Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta   Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF  ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Get my FREE eBook and audiobook about podcasting ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com  ✅ Podcasting course https://www.kimnewlove.com/podcasting  ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23**      Thank you for listening to episode 335 of The Pharmacist's Voice ® Podcast.  If you know someone who would like this episode, please share it with them!

Feeling financially stuck despite making a good income? Tim Ulbrich, PharmD, unpacks three common reasons pharmacists hit a financial plateau and how to reframe your thinking about money, income, and possibility. Episode Summary Do you ever feel like, despite making a good income, you should be further along financially? You've got the degree, the stable job, the six-figure salary…but you're not making the progress you hoped for. You feel stuck, and you're wondering why. In this episode of the Your Financial Pharmacist Podcast, YFP Co-Founder & CEO Tim Ulbrich, PharmD, explores three common reasons many pharmacists feel financially stuck, even with a strong income: A fixed mindset that limits your financial potential A fixed income that hasn't kept up with inflation or your goals Fixed costs that quietly chip away at your freedom and options This isn't just a conversation about budgeting or side hustles. It's about changing how we think about money, income, and what's possible. Whether you're early in your career or feeling stuck mid-way through, this episode will help you gain clarity and take actionable steps toward financial progress. Mentioned on the Show The Big Leap by Gay Hendricks YFP 384: Beyond Salary: Negotiating Your Value in the Workplace Bureau of Labor Statistics (BLS), Pharmacists Book a Discovery Call with the YFP Team

 Tune in to this episode featuring Drs. Neil Skolnik and Sara Wettergreen as they explore the power of storytelling and how it brings us together. Special guests Marlee Seibold and Dr. Saige Kiedinger shared their personal experiences with type 1 diabetes, including— challenges, triumphs, and the everyday moments that have shaped their journeys. We hope that by listening to their stories, you'll gain a deeper understanding of the power of storytelling and feel inspired to share your own journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Marlee Seibold: Storytelling Communications Manager at the ADA and a person living with type 1 diabetes.   Dr. Saige Kiedinger: A recent pharmacy school graduate transitioning to residency training, also living with type 1 diabetes.   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   Want to share your journey with us? Share it now here.

Amina Abubakar, PharmD, AAHIVP, joined Over the Counter to discuss her career journey within the pharmacy profession, from her time in big-box retail to owning an independent pharmacy and continuing education institute.

What does the future of cancer care look like? From replacing IV chemo with oral agents to game-changing advances in bispecific and trispecific therapies, this special bonus episode dives deep into the most exciting—and practice-changing—developments from the 2025 ASCO Annual Meeting.NCODA's Kelly Brunk, PharmD, BCOP, returns from ASCO energized and ready to share his top takeaways in a candid conversation about where oncology is headed. Whether you're a clinician, pharmacist, or anyone in the cancer care ecosystem, this episode is packed with insight you don't want to miss.Bonus: Kelly also shares updates on NCODA's new Immunotherapy Hub and offers a forward-looking take on where the field is headed."The rate of change in oncology care is accelerating—and it's time for practices to be ready, not reactive." — Kelly Brunk Inside the Episode:How oral therapies are reshaping breast cancer treatmentThe evolving role of bispecifics, trispecifics, and antibody-drug conjugatesPractical considerations for implementation: protocols, access, and infrastructureThe importance of quality of life in treatment decisionsEarly use of immune checkpoint inhibitors in multiple disease statesHow AI and equity are shaping the next decade of oncology Listen now and explore what these developments mean for clinical practice—and for the patients at the center of it all. Resources mentioned:NCODA's Immunotherapy Hub – A central resource offering clinical tools, SOP examples, and support for implementing therapies like bispecifics and antibody-drug conjugates.Questions or looking to connect? Email the NCODA Clinical Team at clinical@ncoda.org

What if one compound could dramatically reduce allergic reactions, inflammation, and even medication overload for chronically ill individuals? In this episode, pharmacist Bryana Gregory shares the exciting news of a recent publication in the Journal of Independent Medicine spotlighting the repurposed compound Amlexanox. Originally developed to treat mouth ulcers, Amlexanox has shown powerful anti-inflammatory and mast cell-stabilizing effects, making it a promising alternative to steroids and antihistamines, especially for patients suffering from conditions like Mast Cell Activation Syndrome (MCAS), asthma, and autoimmunity.   Bryana highlights the dramatic transformation of a 60-year-old guest at the Hotze Health & Wellness Center. This patient, who previously relied on 81 medications and supplements, experienced a significant reduction in symptoms and a tapering down to just 17 medications after introducing Amlexanox. The compound worked to stabilize immune responses, reduce histamine overload, and ease inflammatory symptoms without the side effects commonly associated with steroids. Its broader effects have also included improved blood sugar, brain fog, neuropathy, and even weight loss. With a growing body of evidence and support from independent physicians, Amlexanox is gaining recognition as a trusted, natural solution worth exploring.   Watch now and subscribe to our podcasts at www.HotzePodcast.com. For more information about Physician's Preference Pharmacy, please call us at 281-828-9088, or visit https://physicianspreferencerx.com/. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!

In this episode, Kathy Schott sits down with Dr. Kate Smith, clinical faculty and pharmacy education expert, to explore one of the most critical and challenging aspects of training student pharmacists and residents: developing clinical reasoning skills. Drawing from over a decade of experience in both clinical practice and education, Dr. Smith discusses nuanced differences between clinical reasoning, critical thinking, and problem-solving and offers preceptors practical, classroom-tested strategies to support learners. From using patient cases and SOAP notes to applying the "One Minute Preceptor" model, this episode is a must-listen for any pharmacy educator or preceptor aiming to foster confident, capable, and patient-centered practitioners.HostKathy Schott, PhDVice President, Education & OperationsCEimpactGuestKathryn (Kate) Smith, PharmD, BCACPAssociate Professor of InstructionUniversity of Iowa College of PharmacyGet CE: CLICK HERE TO CPE CREDIT FOR THE COURSE!CPE Information Learning ObjectivesAt the end of this course, preceptors will be able to:1. Differentiate clinical reasoning from critical thinking and problem-solving2. Identify practical strategies to teach and assess clinical reasoning skills in student pharmacists and residents in experiential settings.0.05 CEU/0.5 HrUAN: 0107-0000-25-215-H99-PInitial release date: 6/18/2025Expiration date: 6/18/2028Additional CPE details can be found here.The speakers have no relevant financial relationships with ineligible companies to disclose.This program has been:Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.Follow CEimpact on Social Media:LinkedInInstagram

In this thought-provoking episode of RxGenius, host Dr. Ryan Paul Liabenow sits down with Nadia Archambault, PharmD—a pharmacist, certified sexual health therapist, and trailblazing entrepreneur—to unpack the often-misunderstood topic of sexual health. Together, they explore why sexual health is far more than just STI prevention and reproductive function. The conversation dives deep into the psychological, emotional, and relational components of sexuality, highlighting how pharmacists and healthcare professionals can better recognize and support the full spectrum of patient needs. Nadia shares her perspective on common misconceptions, the stigma surrounding sexual well-being, and the importance of approaching patient care with sensitivity, curiosity, and respect for diverse experiences. This episode challenges traditional views and emphasizes the essential role sexual health plays in overall well-being. Key Topics Covered: Redefining sexual health beyond disease prevention The mental and emotional dimensions of sexual well-being Pharmacists' roles in normalizing and supporting sexual health conversations Addressing stigma and tailoring care to diverse identities and needs Nadia's journey from pharmacist to sexual health advocate and entrepreneur Tune in to RxGenius for an open, insightful dialogue that will reshape how you think about sexual health in pharmacy and patient care.

On this episode of The Huddle, Wendy Mobley-Bukstein, PharmD, BCACP, CDCES, CHWC, NASM-CPT, FAPhA, FADCES and Debbie Hinnen, APN, BC-ADM, CDCES, FAAN discuss the importance of medication persistence, how to talk to clients about starting and staying on diabetes medications, and strategies to help clients stay consistent with their medication taking. This episode was made possible with support from Lilly, A Medicine Company.Learn more about the latest in diabetes technology on danatech: danatech l Diabetes Technology Education for Healthcare ProfessionalsLearn more about the ADCES7 Self-Care Behaviors: Self-Care Tips (ADCES7)References:Kennedy-Martin, T., Boye, K. S., & Peng, X. (2017). Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review. Patient Preference and Adherence, 11, 1103–1117. https://doi.org/10.2147/PPA.S136639McGovern, A., Hinton, W., Calderara, S. et al. A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study. Diabetes Ther 9, 229–242 (2018). https://doi.org/10.1007/s13300-017-0361-5Evans M, Engberg S, Faurby M, Fernandes JDDR, Hudson P, Polonsky W. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review. Diabetes Obes Metab. 2022; 24(3): 377-390. doi:10.1111/dom.14603Sabaté E., Adherence to Long-Term Therapies: Evidence for Action, 2003, World Health Organization, Geneva, Switzerland.https://www.ama-assn.org/delivering-care/physician-patient-relationship/8-reasons-patients-dont-take-their-medicationshttps://www.npr.org/sections/health-shots/2017/09/08/549414152/why-do-people-stop-taking-their-meds-cost-is-just-one-reasonhttps://www.adces.org/docs/default-source/handouts/adces7/handout_pwd_adces7_takingmedication.pdf?sfvrsn=4e3f6359_13 Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

In today's episode, supported by Shorla Oncology, we had the pleasure of speaking with Kate Gasparini, PharmD, BCOP, BCPPS, about the use of the oral formulation of imatinib (Imkeldi) for pediatric and adult patients with select leukemias and other malignancies. Gasparini is a pediatric oncology clinical pharmacy specialist at Memorial Sloan Kettering Cancer Center in New York, New York. In our exclusive interview, Gasparini discussed her role as a clinical pharmacy specialist in pediatric oncology, emphasizing her work in patient care, medication reviews, and supportive care. She also noted challenges in administering treatments to patients with dysphagia and emphasized the need for liquid formulations of common therapies. She explained the significance of the availability of the liquid formulation of imatinib, sharing its benefits for patients who struggle with swallowing. Gasparini also addressed potential barriers to accessing this medication, such as insurance coverage limitations, as well as the importance of considering the volume and palatability of liquid formulations to avoid adverse effects and ensure treatment adherence.

In this episode, we explore the Pharm D program at ISU by interviewing one of their current students about the journey they have been on.

When it comes to the airway, roc rocks and succ sucks, right? You've heard it more than once. But EMRA*Cast host Peter Lorenz, MD, presents a nuanced argument in defense of succinylcholine, with guests Mike Perza, PharmD, and Patricia Simmer, MD.

Episode 367: Pharmacology 101: PARP Inhibitors “We know that in cells that are proliferating very quickly, including cancer cells, single-strand DNA breaks are very common. When that happens, these breaks are often repaired by the PARP enzyme, and the cells can continue their replication process. If we block PARP, that repair cannot happen. So in blocking that, these single-strand breaks then lead to double-strand breaks, which ultimately is leading to cell apoptosis,” Danielle Roman, PharmD, BCOP, manager of clinical pharmacy services at the Allegheny Health Network Cancer Institute in Pittsburgh, PA, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about the PARP inhibitor drug class. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by June 13, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the use of PARP inhibitors in cancer care. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Pharmacology 101 series Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 232: Managing Fatigue During PARP Inhibitor Maintenance Therapy Episode 227: Biomarker Testing, PARP Inhibitors, and Oral Adherence During Ovarian Cancer Maintenance Therapy ONS Voice articles: PARP Inhibitors and Ovarian Cancer Genomics May Trick PARP Inhibitors to Treat More Cancers Oncology Drug Reference Sheet: Niraparib ONS books: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (second edition) Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (fourth edition) Safe Handling of Hazardous Drugs (fourth edition) ONS courses: Safe Handling Basics Clinical Journal of Oncology Nursing articles: PARP Inhibition: Genomics-Informed Care for Patients With Malignancies Driven by BRCA1/BRCA2 Pathogenic Variants Talazoparib Plus Enzalutamide in Patients With HRR-Deficient mCRPC: Practical Implementation Steps for Oncology Nurses and Advanced Practice Providers Oncology Nursing Forum article: Familiarity and Perceptions of Ovarian Cancer Biomarker Testing and Targeted Therapy: A Survey of Oncology Nurses in the United States Oral Anticancer Medication Care Compass: Resources for Interprofessional Navigation ONS Biomarker Database ONS Oral Anticancer Medication Learning Library ONS Oral Anticancer Medication Toolkit Oral Chemotherapy Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “The big toxicities here to watch for are primarily hematologic toxicities. It is one of those targeted therapies that does affect blood cell counts. So I'd say the blood cell count that is most commonly affected here is the hemoglobin. So, anemia very frequent complication that we see, probably a little bit more with olaparib compared with other drugs, but we see it as a class side effect. And we can also see neutropenia and thrombocytopenia with these agents, probably a little bit more with niraparib versus the others, but again, you can see it across all of these drugs.” TS 8:16 “We mentioned that rare risk of MDS and AML. This isn't a particularly scary thing if you talk to patients about it. Because of the rarity that we see this, it isn't something that we need to overemphasize, but I think careful monitoring of blood counts in is stressing the importance of that and early intervention here is very important.” TS 16:55 “This is a collaborative effort. And because of the home administration here, these patients do need to be followed very closely. So we are not laying eyes on them usually with the frequency that we do when we have patients actually coming into our infusion centers for treatments—so making sure that there is a plan for regular follow-up with these patients to ensure that they're getting that lab work done, that that's being looked at closely, that we're adjusting the dose if we need to based on that lab work, that we are managing the patient's fatigue. Again, that potentially dose reductions may be needed if patients are having that extreme fatigue.” TS 19:34 “I think one of those [misconceptions] could be that they're only effective in patients that have that BRCA1/2 mutation. And again, remember here that there is some data in particular disease states that we can use them and that they work in the absence of those mutations.” TS 25:12

In this special Father's Day episode, Tim Ulbrich shares five unexpected and powerful money lessons he's learned from raising four boys. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD, reflects on the unexpected and powerful financial lessons he's learned from raising four boys. From conversations at the concession stand to big-picture reflections on priorities, Tim shares 5 meaningful insights that go beyond spreadsheets and savings accounts. Whether you're a parent, planning to be one, or simply interested in how life shapes our money mindset, this episode offers a personal and practical look at the intersection of fatherhood and finance. Mentioned on the Show YFP 363: A Conversation with My Dad: Lessons on Entrepreneurs, Fatherhood, and Finance  YFP 402: Building a Legacy: The Family Constitution Blueprint with Julia Myers Die With Zero: Getting All You Can From Your Money and Your Life by Bill Perkins Happy Money: The Science of Happier Spending by Elizabeth Dunn and Michael Norton  

Episode 053 | Dr. Marthe Dika, MD, FAAD is a board-certified dermatologist and proud owner of M. Dika Dermatology, with practices located in Burlington and Glendale, Wisconsin. At her clinics, she welcomes patients of all ages and skin types, offering comprehensive care for diseases of the skin, hair, and nails. Dr. Dika is particularly experienced in and passionate about managing hair loss and has helped many people who struggle with this often devastating problem.In addition to her clinical work, Dr. Dika is involved in advancing the field ofdermatology through clinical trials conducted at her two locations. Her dedication to research allows her to remain at the forefront of dermatologic advancements and offer her patients cutting edge treatment options.She earned her medical degree from the Medical College of Wisconsin in Milwaukee and completed her residency in dermatology at the University of Iowa. Dr. Dika's commitment to patient care coupled with her passion for dermatology ensures that all who visit M. Dika Dermatology receive the highest quality care tailored to their individual needs.Shout out to Dr. Dika's mentor, Dr. Chesahna Kindred, as mentioned in this episode! Thanks to all the great mentors out there for all that you do. And shout out to the absolutely delightful Whitney Hubbell, PharmD, IBCLC. Dr. Hubbell is currently an all-star Medical Science Liaison at Sanofi, and I'm grateful to her for introducing me to Dr. Dika.This episode was recorded on February 3rd, 2025.Connect with and learn from Dr. DikaM. Dika DermatologyInstagramFacebookMore from Dr. Lewellis and Above & Beyond DermatologyNeed a dermatologist? Fill out this short interest form, text or call me at 715-391-9774, or email me at drlewellis@aboveandbeyondderm.com if you'd like to have a no obligation discovery call. I offer in-office visits, house calls, and virtual care in Wisconsin and virtual care in Illinois, Nebraska, and Colorado.Have an idea for a guest or want to be on the show yourself? Send me a text or email, and we'll see if it's a good fit.Above & Beyond DermatologyNutrafol -- special pricing and physician exclusive productsNeoGenesis -- my favorite source of stem cell released molecules for skin/hairSilagen.biz -- physician dispensed scar refinement products delivered to your door (use practice code 1206240832P)NewsletterLinkedInFacebookDr. Lewellis on InstagramAbove & Beyond Dermatology on InstagramYouTubeTikTokTwitter/XChange Your Mind, Change Your LifeSoMeDocs (Doctors on Social Media)Pippa!

Information on COVID vaccines is moving fast. On May 27th, HHS Secretary Robert F. Kennedy Jr. announced that COVID vaccines will no longer be universally recommended for healthy children or healthy pregnant women. That's a big shift, and understandably, it's raised a lot of questions. We're going to cut through the noise and take a look at where things really stand, who's getting vaccinated, how current guidance is evolving, and what this means for both children and adults as we look ahead to the next respiratory season.  Joining us to help sort it all out is Dr. John Schoen, Senior Clinical Manager of Drug Information at Vizient.     Guest speakers:  John Schoen, PharmD, BCPS  Senior Clinical Manager of Drug Information   Vizient Center for Pharmacy Practice Excellence    Host:  Stacy Lauderdale, PharmD, BCPS  Associate Vice President Vizient Center for Pharmacy Practice Excellence    Show Notes:  [01:38-05:32] What changed in the recent CDC update for healthy children [05:33-09:32] Discussion of COVID-19 outcomes and vaccination in children [09:33-11:47] Specific risk factors for pediatric patients [11:48-12:47] Is the US an outlier for not universally recommending the COVID-19 vaccine for healthy children and making no recommendation in healthy pregnant women? [12:48-14:03] The FDA's proposed regulatory framework for COVID-19 vaccine approval [14:04-15:18] FDA's approach to implementing revised requirements for randomized controlled trials [15:19-16:57] Key discussion points from the May meeting of the Vaccines and Related Biological Products Advisory Committee [17:00-18:27] Topics requiring further clarification about COVID-19 vaccine   Links | Resources: Vizient resources: Minute Market Insight: Potential ACIP COVID-19 recommendation changes April 2025: https://www.vizientinc.com/download?342668 Minute Market Insight: May 2025 COVID-19 vaccine recommendation and policy updates: https://www.vizientinc.com/download?352336 Additional resources: FDA perspective piece published in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMsb2506929 ACIP meeting information: https://www.cdc.gov/acip/meetings/index.html CDC childhood immunization schedule: https://www.cdc.gov/vaccines/hcp/imz-schedules/child-adolescent-age.html CDC adult immunization schedule by medical condition: https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html CDC RESP-NET: https://www.cdc.gov/resp-net/dashboard/ WHO COVID-19 dashboard: https://data.who.int/dashboards/covid19/deaths MMWR - COVID-19–Associated Hospitalizations and Maternal Vaccination Among Infants Aged

What mindset separates high earners from true wealth builders? Inspired by The Millionaire Next Door by Dr. Thomas Stanley, Tim Ulbrich breaks down how changing his perspective on money transformed his financial path, and how it can do the same for you. Episode Summary YFP Co-Founder & CEO, Tim Ulbrich, PharmD explores the key mindset shift that helps pharmacists quietly build lasting wealth. This isn't about flashy cars or overnight success. It's about the habits, discipline, and mindset millionaires use to build wealth quietly and consistently. Drawing from both personal experience and lessons from The Millionaire Next Door by Dr. Thomas Stanley, he shares how pharmacists and other high-income earners can adopt a wealth-building mindset that prioritizes financial independence over lifestyle inflation. Whether you're just getting started or looking to level up, this episode will challenge how you think about money and give you the tools to create lasting change. In this episode, you'll learn: The mindset millionaires adopt (that most people don't) Why high income doesn't guarantee financial freedom How to build money habits that grow wealth over time What these insights mean for pharmacists and other professionals pursuing financial independence Mentioned on the Show First Horizon's Pharmacist Home Loan Your Financial Pharmacist The Millionaire Next Door by Dr. Tom Stanley I Will Teach You to be Rich by Ramit Sethi The Compound Effect by Darren Hardy  

On this episode, we evaluate current guidelines and evidence-based treatment strategies for managing GAD. We define generalized anxiety disorder (GAD) and describe its clinical presentations, diagnostic criteria, and underlying pathophysiology. We also compare and contrast the efficacy, safety profiles, and appropriate use of anxiolytic medications, cognitive behavioral therapy, and lifestyle modifications in treating GAD. Dr. David Osser's Website: https://psychopharm.mobi/algo_live/ Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below:  www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast..  You can get a copy of HPM at the links below:  Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/  If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com